INTANGIBLE ASSETS (Details Narrative)	3 Months Ended		6 Months Ended
	Jun. 30, 2018 USD ($) Number	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($) Number	Jun. 30, 2017 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization expense | $	$ 24,826	$ 17,789	$ 46,023	$ 33,888
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life			20 years
Domestic U.S. Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	19		19
Foreign Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	20		20
Domestic Utility Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	13		13
Domestic Patents - TX-004HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	3		3
Domestic Utility Patent - Pipeline Transdermal Patch Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1
Domestic Utilty Patent - Opera Software [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1
Domestic Patents - TX-009HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1